Treatment for relapsed acute promyelocytic leukemia: what is the best post-remission treatment?

BACKGROUND: Arsenic trioxide (ATO) is the standard treatment for relapsed acute promyelocytic leukemia (APL). However, consensus on post-remission therapies is still lacking. METHODS: We evaluated 52 patients who experienced relapse following initial treatment of APL between 2000 and 2019 at Catholi...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Gi-June, Cho, Byung-Sik, Park, Sung-Soo, Park, Silvia, Jeon, Young-Woo, Yahng, Seung-Ah, Shin, Seung-Hawn, Yoon, Jae-Ho, Lee, Sung-Eun, Eom, Ki-Seong, Kim, Yoo-Jin, Lee, Seok, Min, Chang-Ki, Cho, Seok-Goo, Lee, Jong Wook, Kim, Hee-Je
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492525/
https://www.ncbi.nlm.nih.gov/pubmed/35880495
http://dx.doi.org/10.5045/br.2022.2022060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492525/
https://www.ncbi.nlm.nih.gov/pubmed/35880495
http://dx.doi.org/10.5045/br.2022.2022060

Ejemplares similares